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ABSTRACT 
 
Dengue hemorrhagic fever (DHF) is major public health problem in tropical and subtropical areas of the world with 
lack of approved vaccines and effective antiviral therapies. With no current treatment for illness attributed to dengue 
virus (DENV) infection other than supportive care, therapeutic strategies that use natural extract was developed. 
Indonesia have many plants that potential for antiviral drµgs such as Pterocarpus indicus Willd (P. indicus). The 
objective of this study was to determine the effect of P. indicus to inhibit DENV replication. We used a well-
differentiated hepatocytes-derived cellular carcinoma cell line (Huh-7 it-1 cells) to determine and select antiviral 
activity. The toxicity effects were determined by MTT assay. Then, the suppression of DENV replication was 
determined by Focus assay. Dengue infected cells with DMSO were used as control. We found that crude extract 
(Pi), hexane (Pi.1) and ethyl acetate (Pi.2) extract showed strong inhibition with high selectivity index (SI) of 1,392; 
285.36 and 168.56 respectively.  Sub fraction of Pi.1 and Pi.2 still showed strong inhibition with high SI.  Further 
sub-sub fraction of Pi.2 such as Pi.2.12 and Pi.2.12.1 still showed inhibition of DENV replication but there was 
reduction of SI value. The mechanism experiment of Pi.2.12, we found that Pi 2.12 more profound to inhibit in the 
post infection stage that entry or pre-infection. We conclude that the sub-fraction of Pi.2.12 has potential antiviral 
activity against DV infection in vitro. Further studies are still needed to investigate the pure compound of Pi.2.12 
that inhibit and have advantages in the future as alternative for treatment of DENV infection. 
 
Keywords: Bioactivity, bioactive compounds, effectivity, Neesia altissima Bl., Streptomyces sp. 
INTRODUCTION 
Increasing in mobilization, global warming, lack of 
vaccine and specific treatment, DENV (DENV) become 
a major public health problem in tropical and subtropi-
cal areas of the world. In Indonesia, the number of re-
ported cases started to rise in 2004 and reached a peak 
between 2007 and 2009. In 2015 incidence rate of DENV 
infection in Indonesia was 126,675 cases of DHF with 
1,229 people dead [1]. Even though its high incidence, 
the challenges to find out antiviral against DENV have 
not been success full yet until today because there is lim-
ited understanding of how the pathogens typically be-
haves and how the virus interacts with the immune sys-
tem. Thus, no effective vaccines or therapeutics are cur-
rently available for prevention or treatment of DENV 
infection. Antiviral against DENV have been under de-
velopment since the 1940s. Despite current efforts to 
control dengue, based primarily on vector control and 
case management, the burden and costs of the disease 
remain considerable. 
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DENV causes a wide variety of symptoms in people 
with ranges from dengue fever (DF), an acute, self-lim-
iting febrile illness, to the more severe and life-threaten-
ing dengue hemorrhagic fever and shock syndrome 
(DHF/DSS) [2]. Better management of the dengue 
needs balanced approach involving various aspects like 
disease prevention, cure/treatment, and the vector con-
trol, simultaneously [3]. Despite an annual number of 
infections approaching 50 million worldwide and a rise 
in disease severity, the effective anti-dengue treatment 
and approved vaccines remain a challenge [2]. Consid-
ering the described problems above, drug discovery re-
search for dengue is of great importance.  
DENV genome is composed of approximately 
10,600 nucleotides, single stranded positive sense RNA. 
It contains a single open reading frame that is flanked 
by two un-translated regions; 5` and 3` un-translated 
region (UTR). There are four distinct serotypes of 
DENV known as DENV-1, DENV-2, DENV-3, DENV-
4 [4]. The treatment of DENV was developed based on 
the characteristics of DENV. An antiviral drug that tar-
gets a common host pathway could provide an ad-
vantage to the issues faced by therapies targeting viral 
enzymes or mechanisms, such as viral heterogeneity and 
the emergence of drug resistant mutants.  In vitro study 
showed that there was inhibition of 4 serotype of DENV 
replication in Huh 7.5 cell line using seaweed extract [5]. 
Statistical analysis showed an eight seaweed extracts 
such as Phaeophyta: Canistrocarpus cervicornis, Padina 
gymnospora; Rhodophyta: Palisada perforate; Chloro-
phyta: Caulerpa racemosa were able to reduce DENV 
infection cycle, such as binding or internalization of at 
least one serotype tested [5]. 
The development of specific treatment has been 
moved to in vivo study. Perry et al. 2013 described an 
amino sugar drug UV-4 to protect lethal DENV chal-
lenge in AG129 mice [6] with lacking the type I and II 
interferon receptors [7]. They found that administration 
of UV-4 reduced mortality, as well as viremia and viral 
RNA in key tissues, and cytokine storm [7].  
Indonesia have many plants that potential for anti-
viral drugs such as Pterocarpus indicus Willd (P. indi-
cus). P. indicus belongs to family Leguminosae and has 
been used as green plant all over big city in Indonesia. 
In Indonesia, this plant is recognized as Sono kembang 
and Cendana Merah [8]. Other researcher has identified 
and evaluated effect of P. indicus to the inhibition of 
bacteria growth. The leaves, root and stem barks of P. 
indicus were successively partitioned with petrol, di-
chloromethane, ethyl acetate, butanol, and methanol. 
All the fractions exhibited a wide spectrum of antibacte-
rial activity. The activity was more pronounced in the 
butanol and methanol fractions [9]. The bark of P. indi-
cus becomes a kind of red crystal after some hours of 
exposure to air, which is used as an astringent and 
against other diseases [10]. The structural analysis shows 
that the crystal is a macromolecular compound of tannic 
condensation and glucoside [10]. 
We examined the antiviral effect of P. indicus leaves 
to DENV-1 strain IDS 11/10 in Huh-7 it-1 cells in vitro. 
DENV-1 strain IDS 11/10 was isolated from DF patient 
in the community of Jakarta, Indonesia in 2010. The 
purpose of this study was to determine the dose and 
mechanism of inhibition of P. indicus that can be used 
to inhibit DENV replication. 
 
MATERIALS AND METHODS 
Collection of plants and preparation of plant extract 
P. indicus leaves were collected from Research Cen-
ter for Chemistry, Indonesian Institute of Science 
(LIPI), Indonesia as previous study description [11].  
The botanical identities of each plant were determined 
and authenticated by the Botanical in Research Center 
for Biology LIPI. After the taxonomy identification, the 
plants were washed and cleaned prior to air drying at 
room temperature. The extract was initially partitioned 
with n-hexane, ethyl acetate, butanol, and water. The 
antiviral candidate from ethyl acetate fraction was sub-
jected to silica gel column chromatography with diluents 
of n-hexane and ethyl acetate with equal volume. The 
major fraction was monitored in TLC and all fractions 
were tested for antiviral to DENV. Furthermore, the 
candidate was purified by Sepadex LH-20 column using 
50%, 60% and 80% of methanol.  
 
Preparation of plant extracts for in vitro testing 
Extract, fractions and sub fraction were diluted at 
concentration of 100 mg/ml in dimethyl sulfoxide 
(DMSO) (Sigma Aldrich, USA) as a stock solution.  
Centrifugation was done to remove insolve material. 
The stock solution was diluted with culture medium to 
serial dilution for the assays.  
 
Maintenance of Huh-7 cells 
Dulbecco’s Modified Eagle’s Medium (DMEM) 
High glucose cat no 11965-092 (GIBCO, UK) was used 
for maintenance and antiviral assay on Huh7it-1 cells.  
The cryo-preserved Huh7it-1 cells were rapidly thawed 
at 37°C. Cells were transferred carefully to 25 cm2 tissue 
culture flasks (Corning, USA) containing 5 mL of 
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DMEM with 10% of Fetal Bovine Serum (FBS) 
(GIBCO). Cells were then incubated at 37°C with 5% 
CO2 for 4-5 days until confluent.   
 
Preparation of DENV 
We used DENV isolated from patients IDS 11/10 in 
Jakarta in 2010. C6/36 cell line was used to isolate 
DENV at Department of Microbiology, Faculty of Med-
icine, University of Indonesia [12]. The presence of 
DENV in supernatant of C6/36 cell was checked by HA 
[13] and plaque assay [12]. When the supernatant cell 
showed positive by HA or plaque, we propagated DENV 
in T-75 flask. A monolayer of C6/36 cell in T-75 flasks 
were infected with DENV at an moi 0.5 FFU/cell and 
incubate at 28oC for 7 days. During the time of virus 
propagation, the FBS concentration of the cell culture 
medium was reduced to 2%. Supernatant was harvested 
and centrifuged at 900 g for 5 minutes. Subsequently, 
filtered using a syringe driven 0.22 mm (Millipore, Co. 
Bedford MA USA). Culture supernatant was subse-
quently stored at -80°C and checked for the titer of 
DENV by plaque assay [12] or focus forming assay on 
Vero cell [14]. Supernatant was then collected and 
stored at -80°C. These were repeated for several times 
until adequate virus stock was collected. In this study we 
used DENV-1 at 5 to 10 passages. 
DENV strain IDS 11/10 confirmed by Reverse 
Transcription Polymerase Chain Reaction [15] and se-
quencing. The DENV obtained was confirmed to be 
DENV-1 (data not shown).  
 
Determination of cytotoxicity (CC50) 
In vitro cytotoxicity (CC50) was determine by viabi-
lity of Huh-7 cells after treated with natural extract. The 
viability assay was initiated by seeding 2 × 104 cells into 
96 well flat-bottom tissue culture plates (Corning, USA). 
A blank control (medium only) and cell control (cells 
only) were also plated. After 24 hours, the cells were 
treated with diluted stock of extracts at the concentra-
tions ranging from 0.1 to 80 µg/mL, incubated at 37oC, 
5% CO2. After 48 hours, 20 µL of 3-(4,5-Dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Pro-
mega) salt solution was added into each well and incu-
bated for 4 hours. The absorbance reading of each well 
was measured using micro plate reader at 490 nm. The 
percentage of cell viability and toxicity was further de-
termined based on the absorbance readings. We calcu-
lated the theoretical percentage toxicity of the samples 
by dividing the mean blanked sample ODs by the mean 
blanked control ODs for each sample. 
We used percent viability to represent cytotoxic 
effect. The viability of the cells was determined by this 
following equation: 
 
𝐶𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 =
?̅? 𝑂𝐷 𝑜𝑓 𝑆𝑎𝑚𝑝𝑙𝑒
?̅? 𝑂𝐷 𝑜𝑓 𝐷𝑀𝑆𝑂
× 100% 
 
The percentage viability cell, we used to determine 
CC50. The CC50 was obtained from nonlinear regression 
analysis of concentration-effect curves by the Graph and 
represented means ± standard deviation experiments. 
 
Determination of antiviral activity (IC50) 
A total of 2 × 104 cells/well were seeded into 96 well 
plate and incubated at 37°C with 5% CO2. After 24 
hours, the cells were infected with DENV-1 at a m.o.i. 
of 1 FFU/cell which contained various concentration of 
natural extract. Those concentration were 40 µg/mL, 20 
µg/mL, 10 µg/mL, 5 µg/mL, 0.25 µg/mL and 0.125 
µg/mL. After 2 hours infection, added 100 µL of  DMEM 
+2% FBS contained various concentration of natural 
extract. Plates were further incubated at 37°C for 3 days. 
Then we harvested to determine antiviral activity by 
counting the virus titer with focus assay [14] with slight 
modification. Briefly, the mixtures of 10-fold serial dilu-
tion of viral supernatant was inoculated onto Vero cell 
monolayer in duplicate wells. Absorption was carried 
out at 35oC in 5% CO2 for 2 hours with agitation at 30 
minutes interval. Methylcellulose 1.5% overlay medium 
was added and infected Vero cells were incubated at 
35oC in 5% CO2 for 3 days. The infected Vero cells were 
fix with 10% formaldehyde in PBS and incubated at 
room temperature for 1 hour.  The cells were washed 
with PBS  3 times. As much as 100 µL /well of 1% of 
Nonidet P40 were added to each well and incubated at 
room temperature for 30 minutes. Then, the cell was 
blocked with 5% skim milk in PBS and incubated at 
room temperature for 1 hour. After washed, the cell was 
added with 1/1000 of human IgG anti dengue and incu-
bated at room temperature for 1 hour. We used 1/1000 
antihuman IgG labeled HRP as a secondary antibody. 
After washed, we added substrate and observed infected 
cell with brown color. The result from focus assay was 
used to determine IC50 with following equation: 
 
𝐼𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 (%) =
?̅? 𝑡𝑖𝑡𝑒𝑟 𝐷𝑀𝑆𝑂 − ?̅? 𝑡𝑖𝑡𝑒𝑟 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑡𝑖𝑡𝑒𝑟 𝐷𝑀𝑆𝑂
× 100% 
 
Based on percentage inhibition, we able to deter-
mine IC50. The IC50 was obtained from nonlinear regres-
sion analysis of concentration-effect curves by the graph 
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and represented the means ± standard deviation experi-
ments. 
 
Statistically analysis 
The normality of percentage of viability and inhibi-
tion of infection was analyzed by Shapiro Wilk. Statisti-
cal difference among treatments and control was ana-
lyzed using ANOVA at p value less than 0.05 (p < 0.05).  
 
RESULTS AND DISCUSSION 
IC50, CC50 and SI of P. indicus 
The crude extract of P. indicus leaves showed con-
centration to inhibit 50% of DENV replication (IC50) 
of < 0.125 µg/mL. The hexane and Ethyl acetate fraction 
of P. indicus leaves showed very strong inhibition of 
DENV replication with IC50 of < 0.125 µg/mL. In the 
other hand, butanol and water fraction of P. indicus 
leaves indicated low inhibition of DENV replication 
with IC50 of 15.68 µg/ml and 20.76 µg/mL, respectively 
(Table 1). 
Base on viability assay, the crude extract of P. indi-
cus leaves showed low cytotoxic with concentration to 
destroy 50% of cells (CC50) of 174.31 µg/mL. The hex-
ane and ethyl acetate fraction of P. indicus leaves showed 
CC50 of 35.67 µg/mL and 21.07 µg/mL. Butanol and 
water fraction of P. indicus leaves gave almost similar 
result of the CC50: 11.75 µg/mL and 21.37 µg/mL, re-
spectively (Table 1). 
The selectivity index (SI) was formulated by divid-
ing CC50 with IC50. The SI of crude extract of P. indi-
cus showed high SI value of 1,392. The hexane and ethyl 
acetate fraction of P. indicus leaves showed SI value of 
285.36 and 168.56. Butanol and water fraction of P. in-
dicus leaves gave SI value of 0.75 and 1.03 respectively 
(Table 1). 
 
IC50, CC50 and SI of Sub-fraction of P. indicus  
Based on the SI value and chemical characteristic, 
we continued sub-fraction of Pi .2 not Pi.1. We got 16 
sub-fractions. We screened those sub-fractions only with 
single dose of 30 ug/mL. The percentage of viability and 
infectivity was shown in Figure 1. Pi.2.9 and Pi.2.10 
showed high viability with 100% of inhibition DENV 
infection. Similar result was shown after treated with 
Pi.2.11, Pi.2.12; Pi.2.13; Pi.2.14 and Pi.2.15. The high 
viability and without any infection also were shown after 
treated with Pi.2.17 and Pi.2.18 
 
IC50, CC50 and SI of sub-fraction of P. indicus 
We continued to determine IC50, CC50, and Se lec-
tivity Index (SI) of sub-fraction of P. indicus in Huh-7 
Table 1. Results of IC50, CC50 and Selectivity Index (SI) of crude extract of P. indicus 
Component Code CC50 (µg/mL) IC50 (µg/mL) Selectivity Index (SI) 
Crude Extract Pi 174.31 < 0.125 >1,392.00 
Hexane  Pi.1 35.67 < 0.125 > 285.36 
Ethyl acetate  Pi.2 21.07 < 0.125 >168.56 
Butanol Pi.3 11.75 15.68 0.75 
Water Pi.4 21.37 20.76 1.03 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  The percentage of viability (black) and infectivity (white) of sub-fraction of Pi.2 with single dose of 30 µg/mL 
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Table 2.  IC50, CC50 and Selectivity Index (SI) of sub fraction of 
P. indicus 
Sample CC50 (µg/mL) IC50 (µg/mL)  SI  
Pi.2.9 424.6 26.8 15.84 
Pi.2.10 228.9 26.2 8.72 
Pi.2.11 27.5 10.3 2.65 
Pi.2.12 72.4 3.8 19.05 
Pi.2.13 401 15.9 25.22 
Pi.2.14 60 3.03 19.8 
Pi.2.15 295.4 15.1 19.56 
Pi.2.17 217 24.8 8.75 
Pi.2.18 1288 40 32.2 
Pi.2.12.1 1174 48.6 24.16 
 
Table 3. The percentage of inhibition of  DENV infection at 
entry stage, pre, post and pre-post infection of DENV 
by Pi.2.12. at concentration of 10 µg/mL 
Treatment 
Inhibition of infectivity 
Average (%) SD 
Entry 24.23 6.11 
Pre 63.65 2.88 
Post 90.19 1.15 
Pre- and post- 100 0 
 
cells which high inhibition and low cytotoxic (Table 1). 
We found that Pi.2.18 has the strongest antiviral activity 
compare with another sub-fraction.  Some of P. indicus 
sub-fractions such as Pi.2.12, Pi.2.13, Pi.2.14, and 
Pi.2.15.1 were very low cytotoxic effect to the Huh-7 
cells. 
 
IC50, CC50 and SI of sub-fraction Pi 2.12.1  
Due to chemical characteristic, strong inhibition 
and practical to isolate the pure compound, we contin-
ued to sub fraction on Pi 2.12. From the sub fraction we 
found fraction that we code it as Pi 2.12.1. We evaluated 
the effect of Pi2.12.1to the replication of DENV using 
focus assay. Pi 2.12.1 showed IC50, and CC50 of 1,174 
µg/mL and 48.6 µg/mL respectively (Table 2). The se-
lectivity index of Pi 2.12.1 was 24.16. 
 
The mechanism of inhibition (pre- and post-inhibition) 
Beside continuing sub fraction of Pi 2.12, we also 
determined the inhibition mechanism by which Pi.2.12 
inhibit DENV replication. We used single dose of 10 
µg/mL (above IC50 value) of Pi.2.12 (Table 2). We 
found that treatment at entry step, that mean addition 
of Pi.2.12 to block DENV receptor at Huh7 it-1 showed 
lowest inhibition (24.23%) of DENV replication. Addi-
tion of Pi.2.12 at DENV infected Huh7 it-1 cell (post 
infection) showed strong inhibition (Table 3). Similar 
result was found in pre- and post-inhibition. Pre- and 
post-inhibition mechanism was strongest compare all of 
treatments with 100% inhibition (Table 3). 
The important properties of medicinal plants since 
it has multiple targets, minor side-effects, low resistance 
due to selective pressure of infective agents and low cost 
[16, 17, 18, 19]. Recently, with high technology in chem-
istry and particularly of extraction methods, active prin-
ciples of such medicinal plants have been isolated and 
studied. This result became templates for the synthesis 
of analogue drugs and thus heralded the advent of syn-
thetic drugs [20]. Bark of P. indicus showed carcinostatic 
effect on ascetic mice with Erlich carcinoma [21]. Vari-
ous extracts of leaves, root, and stem barks of P. indicus 
were studied for antibacterial activity. All fractions ex-
hibited a wide spectrum of antibacterial activity, more 
pronounced in the butanol and methanol fractions [9]. 
In a screening for potential therapeutic agents 
against DENV, we evaluated leaves extract of P. indicus 
from Indonesia. The crude extract of P. indicus (Pi) have 
antiviral effect to DENV with high selectivity Index. 
Hexan (Pi1) and ethyl acetate (Pi2) of P. indicus leaves 
extract exerted a strong inhibitory effect against DENV 
with selectivity index of 285.36 and 168.56, respectively.  
Other study found that ethanol extract of P. indicus 
leaves showed strong inhibition on Staphylococcus au-
reus growth but low inhibition in Streptococcus py-
ogenes and Escherichia coli [22]. Chloroform extract did 
not show any inhibition in bacteria growth [22]. Crude 
extract showed strong inhibition in contrast sub–sub 
fraction of Pi.2 with code of Pi 2.12.1 even low cytotoxic 
but did not show strong inhibition even Pi.2.12 showed 
strong inhibition. This result indicated that purification 
has led to loss of activity, which suggests that compo-
nents of the crude extract acted either in synergy or ad-
ditively to produce the antiviral activity. Situations 
where purification has led to loss of activity have been 
reported. Even not in all cases, fractionation of Tama-
rindus indica led to loss of activity to E. coli [23]. In the 
study of antifungal activity, demonstrated the lost activ-
ity in some medicinal plants after the separation of the 
plant extracts into precipitant and supernatant [24]. 
Understanding of the relevant events during early 
DENV infection has been improved the specific inhibi-
tors from natural extract. DENV is a positive-strand  
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RNA virus and contain three structural proteins: the 
capsid (C), the membrane (M), and the envelope (E) 
protein [25]. In the infected cell, the M protein is pro-
duced as a precursor protein called prM, which its func-
tion as a chaperone during the folding and assembly of 
the E protein [26, 27]. The initial step in the life cycle of 
DENV is attachment of the virus to a cellular receptor. 
DENV has been proposed to bind to the glycosamino-
glycan heparan sulfate, which is expressed on many cell 
types [28, 29, 30, 31]. Study in vitro investigated the cell 
entry characteristics of DENV-2 strain S1 on mosquito, 
BHK-15, and BS-C-1 cells [32]. It was observed the par-
ticles that did bind to the cells showed different types of 
transport behavior leading to membrane fusion in both 
the periphery and perinuclear regions of the cell. Mem-
brane fusion was observed in 1 out of 6 bound virus 
particles, indicating that a substantial fraction of the vi-
rus has the capacity to fuse. Fusion occurs exclusively 
from within acidic endosomes. In the experiment to de-
termine DENV inhibition mechanism by which we used 
a single dose of 10 µg/mL (above IC50 value) of Pi.2.12 
(Table 2). We found that treatment at entry step, that 
mean addition of Pi.2.12 to block DENV receptor at 
Huh7 it-1 showed lowest inhibition (24.23%) of DENV 
replication. Addition of Pi.2.12 at DENV infected Huh7 
it-1 cell (post infection) showed strong inhibition (Table 
3). Similar result was found in pre- and post-inhibition. 
Pre- and post-inhibition mechanism was strongest com-
pare all of treatments with 100% inhibition (Table 3). 
Previous study has investigated the parameter spe-
cific standardization shown organoleptic extract P. indi-
cus (thick, blackish brown green color, weak and do not 
have special odor, and bitter tasted), with the content of 
water-soluble compounds (22.88 ± 0.41 to 24.44 ± 3.98), 
and ethanol-soluble (13.62 ± 1.206 to 15.37 ± 0.72), and 
total flavonoid levels (3.88% - 4.02%). The result of non-
specific parameters test shown that the content of water 
(13.84 ± 3.59 to 20.60 ± 2.13), drying shrinkage (15.85 ± 
1.58 to 33.37 ± 2.84), ash extract (5.51 ± 0.57 to 7.63 ± 
1.53), insoluble ash in acid (0.06 ± 0.04 to 1.49 ± 0.25), 
and specific gravity (1.01 ± 0.002 to 1.02 ± 0.01). The 
microbial contamination test resulted (60* to 130*colo-
nies/g), while the test of mold yeasts contamination (0 
to 45* colonies/g × 10-3 mg/kg), material lead (0.002 to 
0.003 mg/kg), and cadmium (0.000011 to 0.000021 mg/ 
kg). as well as arsenic (0.208 × 10-3 mg/kg - 0.956 [11]. 
P. indicus was a good source of traditional medicine 
and it provides a noteworthy basis in pharmaceutical bi-
ology for the development or formulation of new drugs 
and future clinical uses to combat DENV infection. Fur-
ther studies needed to determine mechanism of inhibi-
tion of infection using crude extract of P. indicus. Since 
it has antiviral effect to DENV with high selectivity In-
dex. 
 
CONCLUSION 
Crude extract (Pi), hexane (Pi.1) and ethyl acetate 
(Pi.2) extract showed strong inhibition with high selec-
tivity index (SI) of 1,392; 285.36 and 168.56 respectively. 
The mechanism action of sub- sub fraction Pi.2, showed 
that Pi 2.12 more profound to inhibit in the post infec-
tion stage that entry or pre-infection. Sub-sub fraction 
of Pi.2.12 has potential antiviral activity against DV in-
fection in vitro. 
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